Literature DB >> 16761015

The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukemia.

C Fegan, J Starczynski, G Pratt, C Pepper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16761015     DOI： 10.1038/sj.leu.2404280

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  The role of FAS, FAS-L, BAX, and BCL-2 gene polymorphisms in determining susceptibility to unexplained recurrent pregnancy loss.

Authors:  Rafael Tomoya Michita; Francis Maria Báo Zambra; Lucas Rosa Fraga; Maria Teresa Sanseverino; Lavínia Schuler-Faccini; José Artur Bogo Chies; Priscila Vianna
Journal:  J Assist Reprod Genet       Date:  2019-04-02       Impact factor: 3.412

2.  BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy.

Authors:  Xiaoting Wang; Youdong Lin; Fenghua Lan; Yinghao Yu; Xuenong Ouyang; Wei Liu; Feilai Xie; Xuzhou Wang; Qiaojia Huang
Journal:  Med Oncol       Date:  2014-09-30       Impact factor: 3.064

3.  The -938A/A genotype of BCL2 gene is associated with esophageal cancer.

Authors:  Zhigang Liu; Ruifang Sun; Weidong Lü; Chengxue Dang; Yangrong Song; Cheng Wang; Xi Zhang; Le Han; Hao Cheng; Wei Gao; Jia Liu; Guangyan Lei
Journal:  Med Oncol       Date:  2011-12-21       Impact factor: 3.064

4.  Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.

Authors:  S Dholariya; R Mir; M Zuberi; P Yadav; G Gandhi; N Khurana; A Saxena; P C Ray
Journal:  Clin Transl Oncol       Date:  2015-07-25       Impact factor: 3.405

5.  The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia.

Authors:  Gabriela Kniphoff da Silva Lawisch; Vanderlei Biolchi; Gabriela Kaufmann; Gabriela Nicolai; Eduarda Capitaneo; Thais Regina Rosembach; Janaina Zang; Ilma Simoni Brum; José Artur Bogo Chies
Journal:  Mol Biol Rep       Date:  2022-08-21       Impact factor: 2.742

6.  Evaluation of Bax and Bak gene mutations and expression in breast cancer.

Authors:  Naglaa Mohamed Kholoussi; Sobhy E H El-Nabi; Nora Nassef Esmaiel; Naser Mohamed Abd El-Bary; Ahmed F El-Kased
Journal:  Biomed Res Int       Date:  2014-02-09       Impact factor: 3.411

Review 7.  Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Authors:  Roman Hrstka; Philip J Coates; Borivoj Vojtesek
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

8.  Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Authors:  Sushil Kumar Sahu; Tathagata Choudhuri
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.